Skin cancer: men are genetically more prone
As COVID-19 restrictions loosen this summer, Canadians will spend more time outdoors and make the most of the sunshine. A new study from 平特五不中 suggests why men may be more genetically prone to develop skin cancer.
The research led by Professor Ian Watson of 平特五不中鈥檚 Goodman Cancer Research Centre (GCRC), published in the journal Nature Cancer, identified three genes on the X chromosome with significant mutations. Females have two X-chromosomes whereas males have an X and a Y chromosome. 鈥淥f the three significantly mutated genes we found on the X-chromosome, only one gene had a specific type of mutation found only in males,鈥� says Prof. Watson.
Females can develop other types of mutations in the gene in question, but since they have two X chromosomes (males have one), they have two copies, allowing the second to serve as a backup if the first becomes mutated. 鈥淭hese mutations may help explain why male melanoma patients have higher incidence and worse survival rates,鈥� says Rached Alkallas, a PhD student at 平特五不中 and the study鈥檚 co-first author.
Genetic changes and UV
One of the most important risk factors for melanoma skin cancer is ultraviolet (UV) radiation from the sun and indoor tanning. By shedding light on specific genetic changes caused by UV exposure, advances in gene sequencing techniques have given researchers the ability to dig deeper into the underlying causes for the sex differences in melanoma. After analyzing genetic mutations in more than a thousand melanoma cases, researchers have provided some insight behind this mysterious sex bias. 鈥淲e鈥檙e continuing to do more research in this area, including determining how these mutations affect melanoma biology and respond to immunotherapy,鈥� explains Mathieu Lajoie, PhD, research associate and study co-lead.
More effective personalized treatment on the horizon
鈥淚mmunotherapy has been life-changing for many melanoma patients,鈥� Prof. Watson says of the form of treatment that reactivates a cancer patient鈥檚 immune system to get rid of cancer cells. 鈥淯nfortunately, a large subset of patients still don鈥檛 respond to this treatment and we鈥檙e working in collaboration to understand where the problems lie in order to connect all the dots.鈥�
In addition to the role gender plays in different incidence and survival rates, data is beginning to emerge that suggests they may also have different response rates to the latest forms of therapy. Watson is investigating whether the sex difference in mutations he uncovered might help explain the reason. Deepening our knowledge of the genetics of various melanoma subtypes could also go a long way in providing personalized treatment whereby patients are matched with the therapies that are most likely to treat their specific cancer.
About this study
鈥�,鈥� by R. Alkallas, M. Lajoie, I. Watson, et al, will be published online on June 22 in Nature Cancer. Doi: 10.1038/s43018-020-0077-8
About 平特五不中
Founded in Montreal, Quebec, in 1821, 平特五不中 is Canada鈥檚 top ranked medical doctoral university. 平特五不中 is consistently ranked as one of the top universities, both nationally and internationally. It is a world-renowned institution of higher learning with research activities spanning two campuses, 11 faculties, 13 professional schools, 300 programs of study and over 40,000 students, including more than 10,200 graduate students. 平特五不中 attracts students from over 150 countries around the world, its 12,800 international students making up 31% of the student body. Over half of 平特五不中 students claim a first language other than English, including approximately 19% of our students who say French is their mother tongue.
